Labiotech.eu

News and Trends 18 Jan 2018

France Gets Ready to Test CAR-Treg Cells to Avoid Transplant Rejection

TxCell has received a €1.2 loan from Bpifrance to complete preclinical trials with its CAR-Treg technology for transplant rejection and start human testing. French biotech TxCell is finalizing the preparations to take its first cell therapy to clinical trials. The treatment, called HLA-A2 CAR-Treg, is intended for the prevention of chronic rejection after organ transplantation. […]

January 18, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 18 Jan 2018

Meet the 10 Promising Synbio Startups in RebelBio’s London Cohort

Irish accelerator RebelBio has launched its latest cohort of startups that will receive its support during a 3-month program at Imperial College London. RebelBio is a startup accelerator that helps entrepreneurs to build technology associated with the life sciences field. It offers seed funding, lab space, mentorship, and a community of successful and diverse founders […]

January 18, 2018 - 4 minutesmins - By Alex Dale

autoimmune diseases psoriasis arthritis 1

News and Trends 18 Jan 2018

This Cytokine is Key to Autoimmune and Inflammatory Diseases

An international group of researchers has found that the cytokine IL-23 is heavily involved in autoimmune and inflammatory diseases, opening the door to new therapies targeting the molecule. Research at the VIB-UGent Center for Inflammation Research has identified a crucial molecular mechanism underlying autoimmune and inflammatory diseases like psoriasis, rheumatoid arthritis, and multiple sclerosis. The study, […]

January 18, 2018 - 3 minutesmins - By Alex Dale

More News! 18 Jan 2018

First Patient Successfully Implanted with Heart Valve Replacement Device

French company Kephalios has successfully implanted a new adjustable device to repair a heart valve defect in a human patient for the first time. The first of five patients in a clinical trial at the Vienna General Hospital has received an implant designed to repair mitral valve regurgitation. This disease causes the mitral valve to not close properly […]

January 18, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 18 Jan 2018

Report from JP Morgan 2018: Taking the Financial Temperature of Biotech

As heard at JP Morgan 2018, last year was an ok year for biotech. But how does 2018 look? Here are the thoughts of a panel convened to discuss the numbers. A biotech whirlwind swept through San Francisco last week as the industry descended on Union Square for the JP Morgan Healthcare Conference of 2018. […]

January 18, 2018 - 5 minutesmins - By Evelyn Warner

News and Trends 17 Jan 2018

French Biotech Closes a €18.5M Series B to Boost Colon Cancer Diagnostics

HalioDx hopes that its Immunoscore diagnostics platform can help to provide precision medicine for a number of indications, including colon cancer. HalioDx is an expert in cancer diagnostics, specializing in the analysis of the tumor microenvironment. The company has closed a €18.5M Series B financing round – impressive considering the concerns over reimbursement that investors often have for diagnostic […]

January 17, 2018 - 3 minutesmins - By Alex Dale

owkin artificial intelligence drug development

More News! 17 Jan 2018

€9M Round for AI Algorithms to Speed up Drug Development

Owkin has raised $11M(€9M) in a Series A round to fund its artificial intelligence platform for medical research and drug discovery. Owkin, based in New York and Paris, was founded in 2016 to develop machine learning algorithms that can deal with the overabundance of information in biology to optimize the drug development process. The company […]

January 17, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

More News! 17 Jan 2018

This French Biotech is Developing Kits to Stop Food Poisoning

Novolyze has raised €2.2M to bring its ready-to-use food safety kits to market as quickly as possible and help the hundreds of millions of people affected by food poisoning each year. Novolyze is a French biotech that develops products and services to reduce the risk of foodborne infections. It has raised €2.2M to accelerate its growth in markets […]

January 17, 2018 - 3 minutesmins - By Alex Dale

News and Trends 17 Jan 2018

Here’s Your New Year’s Resolution: Get Your Immune System in Shape

If you’re having trouble deciding on a New Year’s resolution, why not train up your immune system? Scientists believe this could help prevent the side effects of chemotherapy. Researchers at Technische Universitaet Dresden believe that by ‘training’ the immune system, cancer patients undergoing chemotherapy could be spared some of the trauma. The study, published in Cell, […]

January 17, 2018 - 3 minutesmins - By Alex Dale

In Depth 17 Jan 2018

An Update on What’s New in the French Biotech Industry

Here’s a closer look at the French biotech ecosystem in 2017, which remains one the leading industries in Europe along with Germany and the UK. France’s biotech ecosystem is relatively dynamic and well-developed. Young companies harboring exciting technology are encouraged into the industry by support from Bpifrance, i-LAB, and iBionext. Once a company gets off the ground, France is […]

January 17, 2018 - 4 minutesmins - By Alex Dale

News and Trends 16 Jan 2018

Oxford Firm Recruits Two Partners to Build Drug Discovery AI

e-Therapeutics has teamed up with AI experts Intellegens and Biorelate to improve its technology for computer-based drug discovery. Based in Oxford, e-Therapeutics has the mission of reducing the time and money it costs to develop new drugs with the help of artificial intelligence. Its platform can explore large amounts of public and private databases to […]

January 16, 2018 - 1 minutemin - By Clara Rodríguez Fernández

da volterra antibiotic resistance trial 1

News and Trends 16 Jan 2018

This French Biotech’s Medical Device Protects Against Antibiotic Resistance

Da Volterra has achieved impressive early results with its antibiotic resistance-busting medical device by successfully protecting the diversity of the microbiome. French biotech Da Volterra is developing products to fight the rapidly rising rates of antibiotic resistance. During a Phase I study, the company’s medical device, DAV132, was used with the antibiotic, moxifloxacin, and successfully protected the intestinal […]

January 16, 2018 - 2 minutesmins - By Alex Dale

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

France Gets Ready to Test CAR-Treg Cells to Avoid Transplant Rejection

Meet the 10 Promising Synbio Startups in RebelBio’s London Cohort

This Cytokine is Key to Autoimmune and Inflammatory Diseases

First Patient Successfully Implanted with Heart Valve Replacement Device

Report from JP Morgan 2018: Taking the Financial Temperature of Biotech

French Biotech Closes a €18.5M Series B to Boost Colon Cancer Diagnostics

€9M Round for AI Algorithms to Speed up Drug Development

This French Biotech is Developing Kits to Stop Food Poisoning

Here’s Your New Year’s Resolution: Get Your Immune System in Shape

An Update on What’s New in the French Biotech Industry

Oxford Firm Recruits Two Partners to Build Drug Discovery AI

This French Biotech’s Medical Device Protects Against Antibiotic Resistance

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!